Zhejiang Orient Gene Biotech Co Ltd (688298) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Based on the latest financial reports, Zhejiang Orient Gene Biotech Co Ltd (688298) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.52 Million ≈ $-4.47 Million USD) by net assets (CN¥6.49 Billion ≈ $950.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688298 company net worth for the company's overall valuation and market capitalisation.

Zhejiang Orient Gene Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Zhejiang Orient Gene Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Orient Gene Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Orient Gene Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Orient Gene Biotech Co Ltd (688298) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Yongji Printing Co Ltd SHG:603058	0.006x
Abacus Group AU:ABG	0.030x
SECHE ENVIRO.UNSP.ADR 1/5 F:SCB0	N/A
Shandong Astro-century Education&Technology Co Ltd SHE:300654	0.024x
ZH.JIN.ENV.HLDG DL-00001 F:3UG	N/A
Hailir Pesticides and Chemicals Group Co Ltd SHG:603639	0.047x
Meorient SHE:300795	0.027x
Sjóvá-Almennar tryggingar hf IC:SJOVA	0.045x

Annual Cash Flow Conversion Efficiency for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024. View 688298 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.79 Billion ≈ $993.80 Million	CN¥-348.33 Million ≈ $-50.97 Million	-0.051x	+75.83%
2023-12-31	CN¥7.55 Billion ≈ $1.10 Billion	CN¥-1.60 Billion ≈ $-234.43 Million	-0.212x	-158.95%
2022-12-31	CN¥8.32 Billion ≈ $1.22 Billion	CN¥3.00 Billion ≈ $438.40 Million	0.360x	-52.35%
2021-12-31	CN¥6.89 Billion ≈ $1.01 Billion	CN¥5.20 Billion ≈ $761.49 Million	0.755x	+3.44%
2020-12-31	CN¥2.45 Billion ≈ $358.72 Million	CN¥1.79 Billion ≈ $261.98 Million	0.730x	+242.35%
2019-12-31	CN¥254.13 Million ≈ $37.19 Million	CN¥54.21 Million ≈ $7.93 Million	0.213x	+0.12%
2018-12-31	CN¥208.03 Million ≈ $30.44 Million	CN¥44.33 Million ≈ $6.49 Million	0.213x	-12.27%
2017-12-31	CN¥138.12 Million ≈ $20.21 Million	CN¥33.54 Million ≈ $4.91 Million	0.243x	+103.04%
2016-12-31	CN¥98.72 Million ≈ $14.45 Million	CN¥11.81 Million ≈ $1.73 Million	0.120x	--

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$527.76 Million

CN¥3.61 Billion CNY

Market Cap Rank

#12076 Global

#3497 in China

Share Price

CN¥17.89

Change (1 day)

-0.72%

52-Week Range

CN¥17.47 - CN¥28.54

All Time High

CN¥221.47